– CANADA, Vancouver – Lifeist Wellness Inc. (TSXV: LFST / FRA: M5B0 / OTC: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, announced the appointment of current Board member and former CEO, Meni Morim as Chairman of the Board of Directors alongside Board member Branden Spikes named Lead Independent Director.
Meni Morim, who has been the driving force behind Lifeist’s transformation and successful realignment of the Company’s business strategy, assumes the role of Chairman. In this capacity, Meni will continue to provide strategic guidance to Lifeist’s executive team and Board, ensuring the successful execution of the Company’s long-term vision.
Branden Spikes, who served as Chairman of the Board since 2019, and has been instrumental in guiding the Company’s strategic direction, takes on the role of Lead Independent Director to act as the effective leader of the Board and to ensure that the Board’s agenda will enable it to successfully carry out its duties. In this role, Branden will continue to play a critical role in overseeing the Board’s discharge of its duties together with the Chairman, corporate governance, strategic initiatives, and Lifeist’s operations while providing valuable independent oversight of the Company’s management.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to develop innovative products that support human wellness and transform lives. Lifeist’s key asset is its U.S. biosciences subsidiary Mikra Cellular Sciences Inc., a biosciences and consumer wellness company focused on developing and selling innovative wellness products.
For more information: https://lifeist.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.